Advancing our understanding of the molecular causes underlying Alzheimer's disease (AD), especially amyloid-β (Aβ) and tau pathologies, becomes more important as aging populations cause a continuous rise in AD cases globally (1, 2). The gene discussed is MAPT; the disease is early-onset autosomal dominant Alzheimer disease.